|This Slide: #2 of 100|
Slide #2. Balchem Corporation — SensoryEffects
Balchem Corporation (NASDAQ:BCPC)
Highlander Partners, L.P., a Dallas-based investment firm, announces the sale of its portfolio company, SensoryEffects, to Balchem Corporation (NASDAQ: BCPC), a publicly-traded human and animal health and wellness company. The purchase price was $567 million, before working capital and other adjustments. The sale represents the culmination of eight years of collaboration and enterprise building between Highlander Partners and SensoryEffects' founder, Chairman and CEO, Charles A. Nicolais, and the management team he assembled. The investment has been the most successful one in Highlander Partners' history and the firm is grateful to Mr. Nicolais and his team for all their efforts and proud of Highlander Partners' substantial role in partnering with him to build a company that is a clear industry leader and poised to thrive for years to come.
Balchem is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. Co. has four reportable segments: Human Nutrition & Health, which provides human grade choline nutrients and mineral amino acid chelated products for nutrition wellness applications; Animal Nutrition & Health, which provides nutritional products in addition to basic choline chloride; Specialty Products, which provides ethylene oxide and propylene oxide; and Industrial Products, which provides certain derivatives of choline chloride, as well as manufactures and sells methylamines.
BCPC SEC Filing Email Alerts Service
Open the BCPC Page at The Online Investor »
Strong Buy (4.00 out of 4)
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite